Jurgen Kuball
Universiteit Utrecht
H-index: 60
Europe-Netherlands
Top articles of Jurgen Kuball
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response | Maria Alieva Mario Barrera Román Sam de Blank Diana Petcu Amber L Zeeman | 2024/3/19 | |
Engineering BCMA CAR T cells for myeloma-targeted cargo delivery | bioRxiv | Thomas Kimman Marta Cuenca Anne Slomp Ralph G Tieland Dedeke Rockx-Brouwer | 2024 |
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for … | Cytotherapy | Fermin Sanchez-Guijo Joaquim Vives Annalisa Ruggeri Christian Chabannon Selim Corbacioglu | 2024/2/17 |
Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data | Blood Advances | Flores Weverling Mieke Roeven Clara Nijssen Annoek EC Broers Elisabeth Dovern | 2024/4/9 |
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells | Nature Immunology | Patricia Hernández-López Eline van Diest Peter Brazda Sabine Heijhuurs Angelo Meringa | 2024/1 |
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic … | British journal of haematology | Takaaki Konuma Masamitsu Yanada Satoshi Yamasaki Yachiyo Kuwatsuka Takahiro Fukuda | 2018/7 |
Abstract SY45-02: Engineering strategies based on receptors derived from gdT cells | Cancer Research | Jürgen Kuball | 2024/4/5 |
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study | British Journal of Haematology | Frédéric Baron Arnon Nagler Jacques‐Emmanuel Galimard Jaime Sanz Jurjen Versluis | 2024/1 |
Repurposing CD19-directed immunotherapies for pediatric t (8; 21) acute myeloid leukemia | bioRxiv | Farnaz Barneh Joost B Koedijk Noa E Wijnen Tom Meulendijks Minoo Ashtiani | 2024 |
Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey | Annals of oncology: official journal of the European Society for Medical Oncology | P Comoli G Pentheroudakis A Ruggeri Ulrike Köhl F Lordick | 2024/4 |
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML | Journal for ImmunoTherapy of Cancer | Vania Lo Presti Angelo Meringa Ester Dunnebach Alice van Velzen Aida Valera Moreira | 2024 |
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT | Leukemia & Lymphoma | Sun-Hye Ko Jung-Hee Lee Je-Hwan Lee Han-Seung Park Eun-Ji Choi | 2018/8/3 |
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1 | Journal for Immunotherapy of Cancer | Annelisa M Cornel Loutje van der Sman Jip T van Dinter Marta Arrabito Ester Dunnebach | 2024 |
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf … | Bone Marrow Transplantation | Arnon Nagler Myriam Labopin Ryszard Swoboda Alexander Kulagin Andrea Velardi | 2023/9 |
Compositions comprising gamma 9 delta 2 T-cell receptors and methods of use thereof to treat cancer | 2023/6/27 | ||
Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on … | Blood | Simona Pagliuca Jarl Mooyaart Nicolaus Kröger Jürgen Finke Victoria Potter | 2023/11/28 |
Uncovering the mode of action of engineered T cells in patient cancer organoids | Nature biotechnology | Johanna F Dekkers Maria Alieva Astrid Cleven Farid Keramati Amber KL Wezenaar | 2023/1 |
Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit | I Johanna A Daudeij F Devina C Nijenhuis B Nuijen | 2023/12/1 | |
Human leukocyte antigen restricted gamma delta t cell receptors and methods of use thereof | 2023/8/10 | ||
Long Term Outcomes and Renal Response Following Autologous Stem Cell Transplantation for Light Chain Deposition Disease: a Retrospective Study on Behalf of the Cmwp of the EBMT | Blood | Laurent Garderet Luuk Gras Sr Linda Koster Montserrat Rovira Laure Vincent | 2023/11/28 |
